Table 2.
Gel thickness (n=48) | Mean (±SD), mm | Median (range), mm |
---|---|---|
| ||
Base† | 8.0 (±6.9) | 7.5 (0.0–30.3) |
Mid-gland | 10.0 (±4.4) | 9.4 (0.0–21.5) |
Apex†† | 6.7 (±5.6) | 7.1 (0.0–20.8) |
Average gel thickness (base/mid/apex) | 8.1 (±4.2) | 7.1 (2.0–17.9) |
Prostate to inner rectal wall distance (n=48) | Pre-injection, mm | Post-injection, mm | P* |
---|---|---|---|
| |||
Base† | |||
Mean (±SD) | 9.8 (±6.6) | 18.4 (±7.2) | < .0001 |
Median (range) | 8.2 (1.0–25.9) | 18.1 (4.7–34.7) | |
| |||
Mid-gland | |||
Mean (±SD) | 5.8 (±3.7) | 15.5 (±5.8) | < .0001 |
Median (range) | 5.4 (1.0 – 18.6) | 14.6 (5.6 – 34.2) | |
| |||
Apex†† | |||
Mean (±SD) | 5.9 (±3.0) | 12.6 (±5.8) | < .0001 |
Median (range) | 5.6 (1.0–14.1) | 11.7 (4.7–31.3) |
Non-parametric Wilcoxon signed rank test
Measurement taken on axial image 3–5mm caudal to cranial-most aspect of prostate
Measurement taken on axial image 3–5mm cranial to caudal-most aspect of prostate